Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

LRRK1 Antibody

Product Specifications

CAS Number

9007-83-4

Product Name Alternative

LRRK1; KIAA1790; Leucine-rich repeat serine/threonine-protein kinase 1

Swiss Prot

Q38SD2

Host

Rabbit

Reactivity

Human, Rat, Mouse

Immunogen

The antiserum was produced against synthesized peptide derived from human LRRK1. AA range:361-410

Target

LRRK1

Partner Proteins

Leucine-rich repeat serine/threonine-protein kinase 1

Clonality

Polyclonal

Source

Polyclonal, Rabbit,IgG

Applications

IHC, IF, ELISA

Purification

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Concentration

1 mg/ml

Dilution

IHC 1:100 - 1:300. IF 1:200 - 1:1000. ELISA: 1:5000. Not yet tested in other applications.

Modification

Unmodified/Total

Storage Conditions

Store at -20°C/1 year

Specificity

LRRK1 Polyclonal Antibody detects endogenous levels of LRRK1 protein.

Formulation

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

SPSB4 CRISPRa sgRNA lentivector (set of three targets)(Human)
45411121 3x 1.0µg DNA

SPSB4 CRISPRa sgRNA lentivector (set of three targets)(Human)

Ask
View Details
LAMA84-r/iRFP stable cell line
GTR15423931 1 Vial

LAMA84-r/iRFP stable cell line

Ask
View Details
Mouse Zfp109 (NM_020262) AAV Particle
MR213152A1V 250 µL

Mouse Zfp109 (NM_020262) AAV Particle

Ask
View Details
Anti-Human CD270/TNFRSF14 Antibody (36H12), PE
MBS1584976-01 50 Tests

Anti-Human CD270/TNFRSF14 Antibody (36H12), PE

Ask
View Details
Anti-Human CD270/TNFRSF14 Antibody (36H12), PE
MBS1584976-02 100 Tests

Anti-Human CD270/TNFRSF14 Antibody (36H12), PE

Ask
View Details
Anti-Human CD270/TNFRSF14 Antibody (36H12), PE
MBS1584976-03 5x 100 Tests

Anti-Human CD270/TNFRSF14 Antibody (36H12), PE

Ask
View Details